CLOCK and mood disorder: The potential translational value of this finding could be tested by examining whether fluoxetine treatment might exert a beneficial effect on aberrant ultradian rhythms, including disrupted sleep architecture, in a specific subgroup of mood disorder patients presenting with a particular genetic profile, potentially characterized by variants in the sequence and/or expression of one or more clock genes (5–12).